Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Non Operating Income (2018 - 2025)

Dna X's Non Operating Income history spans 8 years, with the latest figure at -$562000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at -$562000.0 for Q4 2025, down 225.17% from a year ago — trailing twelve months through Dec 2025 was -$902000.0 (down 466.67% YoY), and the annual figure for FY2025 was -$902000.0, down 466.67%.
  • Non Operating Income for Q4 2025 was -$562000.0 at Dna X, down from -$161000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $601000.0 in Q4 2022 to a low of -$562000.0 in Q4 2025.
  • The 5-year median for Non Operating Income is -$75500.0 (2023), against an average of -$20250.0.
  • The sharpest move saw Non Operating Income plummeted 2166.67% in 2021, then surged 45000.0% in 2024.
  • Year by year, Non Operating Income stood at $400000.0 in 2021, then skyrocketed by 50.25% to $601000.0 in 2022, then tumbled by 100.17% to -$1000.0 in 2023, then surged by 45000.0% to $449000.0 in 2024, then plummeted by 225.17% to -$562000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$562000.0, -$161000.0, and -$215000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.